Identification of oseltamivir resistance among pandemic and seasonal influenza A (H1N1) viruses by an His275Tyr genotyping assay using the cycling probe method

Journal of Clinical Microbiology

Volumn 49, Issue 1, 2011, Pages 125-130

  Suzuki, Yasushi ^a   Saito, Reiko ^a   Sato, Isamu ^b   Zaraket, Hassan ^a,c   Nishikawa, Makoto ^b   Tamura, Tsutomu ^b   Dapat, Clyde ^a   Caperig Dapat, Isolde ^a   Baranovich, Tatiana ^a   Suzuki, Takako ^a   Suzuki, Hiroshi ^a,d  

^a NIIGATA UNIVERSITY   (Japan)

^b Niigata Prefectural Institute of Public Health And Environmental Sciences   (Japan)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d NIIGATA SEIRYO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

6 CARBOXYFLUORESCEIN; HISTIDINE; OSELTAMIVIR; PRIMER DNA; SIALIDASE; TYROSINE;

ARTICLE; DNA PROBE; DRUG SENSITIVITY; GENE DELETION; GENOTYPE; HUMAN; HUMAN TISSUE; INFLUENZA A (H1N1); INFLUENZA VIRUS A H1N1; NONHUMAN; PANDEMIC INFLUENZA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEASONAL INFLUENZA; SINGLE NUCLEOTIDE POLYMORPHISM;

AMINO ACID SUBSTITUTION; ANTIVIRAL AGENTS; GENOTYPE; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; NEURAMINIDASE; OSELTAMIVIR; POLYMORPHISM, SINGLE NUCLEOTIDE; SENSITIVITY AND SPECIFICITY; VIRAL PROTEINS;

INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 78650853324     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01401-10     Document Type: Article

References (26)

1. Baranovich, T., et al. 2010. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season. J. Clin. Virol. 47:23-28.
2. Centers for Disease Control and Prevention. 2009. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis - North Carolina, 2009. MMWR Morb. Mortal. Wkly. Rep. 58:969-972.
3. Centers for Disease Control and Prevention. 2009. Oseltamivir-resistant novel influenza A (H1N1) virus infection in two immunosuppressed patients - Seattle, Washington, 2009. MMWR Morb. Mortal. Wkly. Rep. 58:893-896.
4. Centers for Disease Control and Prevention. 2009. Update: novel influenza A (H1N1) virus infections - worldwide, May 6, 2009. MMWR Morb. Mortal. Wkly. Rep. 58:453-458.
5. Dapat, C., et al. 2009. Epidemiology of human influenza A and B viruses in Myanmar from 2005 to 2007. Intervirology 52:310-320.
6. Deyde, V., and L. Gubareva. 2009. Influenza genome analysis using pyrosequencing method: current applications for a moving target. Expert Rev. Mol. Diagn. 9:493-509.
7. Deyde, V., et al. 2010. Detection of molecular markers of drug resistance in 2009 pandemic influenza A (H1N1) viruses by pyrosequencing. Antimicrob. Agents Chemother. 54:1102-1110.
8. Deyde, V., et al. 2007. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J. Infect. Dis. 196:249-257.
9. Gubareva, L., L. Kaiser, and F. Hayden. 2000. Influenza virus neuraminidase inhibitors. Lancet 355:827-835.
10. Gubareva, L., L. Kaiser, M. Matrosovich, Y. Soo-Hoo, and F. Hayden. 2001. Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. J. Infect. Dis. 183:523-531.
11. Hayden, F. 2009. Developing new antiviral agents for influenza treatment: what does the future hold? Clin. Infect. Dis. 48(Suppl. 1):S3-S13.
12. Hindiyeh, M., et al. 2010. Rapid detection of influenza A pandemic (H1N1) 2009 virus neuraminidase resistance mutation H275Y by real-time reverse transcriptase PCR. J. Clin. Microbiol. 48:1884-1887.
13. Hoffmann, E., J. Stech, Y. Guan, R. Webster, and D. Perez. 2001. Universal primer set for the full-length amplification of all influenza A viruses. Arch. Virol. 146:2275-2289.
14. Hurt, A., I. Barr, G. Hartel, and A. Hampson. 2004. Susceptibility of human influenza viruses from Australasia and South East Asia to the neuraminidase inhibitors zanamivir and oseltamivir. Antiviral Res. 62:37-45.
15. Kawakami, C., et al. 2009. Isolation of oseltamivir-resistant influenza A/H1N1 virus of different origins in Yokohama City, Japan, during the 2007-2008 influenza season. Jpn. J. Infect. Dis. 62:83-86.
16. McKimm-Breschkin, J., et al. 2003. Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir. Antimicrob. Agents Chemother. 47:2264-2272.
17. Shobugawa, Y., et al. 2009. Emerging genotypes of human respiratory syncytial virus subgroup A among patients in Japan. J. Clin. Microbiol. 47:2475-2482.
18. Sugaya, N., and Y. Ohashi. 2010. Long-acting neuraminidase inhibitor laninamivir octanoate (CS-8958) versus oseltamivir as treatment for children with influenza virus infection. Antimicrob. Agents Chemother. 54:2575-2582.
19. Suzuki, Y., et al. 2010. Rapid and specific detection of amantadine-resistant influenza A viruses with a Ser31Asn mutation by the cycling probe method. J. Clin. Microbiol. 48:57-63.
20. Ujike, M., et al. 2010. Oseltamivir-resistant influenza viruses A (H1N1) during 2007-2009 influenza seasons, Japan. Emerg. Infect. Dis. 16:926-935.
21. van der Vries, E., et al. 2010. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase. J. Clin. Virol. 47:34-37.
22. Wang, B., et al. 2010. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections. Antiviral Res. 87:16-21.
23. World Health Organization. 2009, posting date. Influenza A(H1N1) virus resistance to oseltamivir. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/disease/influenza/oseltamivir-summary-south-2008/en/ index.html. Accessed 13 January 2010.
24. World Health Organization. 2010, posting date. Pandemic (H1N1) 2009 - update 105. World Health Organization, Geneva, Switzerland. http://www.who.int/ csr/don/2010-06-18/en/index.html. Accessed 24 June 2010.
25. World Health Organization. 2009, posting date. Protocol for antiviral susceptibility testing by pyrosequencing. World Health Organization, Geneva, Switzerland. http://www.who.int/csr/resources/publications/swineflu/ pyrosequencing-protocol/en/index.html. Accessed 27 May 2009.
26. World Health Organization. 2009, posting date. Sequencing primers and protocol. World Health Organization, Geneva, Switzerland. http://www.who.int/ csr/resources/publications/swineflu/GenomePrimers-20090512.pdf. Accessed 15 July 2009.